Dare Bioscience Inc. (NASDAQ: DARE)
$3.38
N/A ( 0% ) 23.3K
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Market Data
Open
$3.38
Previous close
$3.38
Volume
23.3K
Market cap
$28.64M
Day range
$3.30 - $3.63
52 week range
$0.27 - $4.08
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
8-k | 8K-related | 13 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
8-k | 8K-related | 15 | May 14, 2024 |
10-q | Quarterly Reports | 83 | May 14, 2024 |
8-k | 8K-related | 14 | Apr 30, 2024 |